Australasian Leukaemia & Lymphoma Group (ALLG) Meetings & Events
The ALLG biannual investigator meetings are working meetings of the membership of the group, not public conferences. The meetings are held in May and November each year.
Next Upcoming Meetings
- 13-15 May 2020, Virtual Meeting
- 13-16 October 2020, W Brisbane
May Scientific Meeting
In response to the Governments requirements for COVID-19 management the ALLG will transition the ALLG Scientific Meeting in May from a traditional face-to-face format to a virtual meeting format.
Conducting the ALLG Scientific Meeting in a virtual format will, most importantly, enable us to continue important discussions about the care of patients involved in clinical trials while avoiding face-to-face interactions.
The new meeting agenda will deliver a series of one and half to two-hour working party sessions scheduled throughout Wednesday (May 13), Thursday (May 14) and Friday (May 15). We are working closely with the Working Party Chairs to finalise the new virtual meeting program, which will be circulated in due course. We will communicate the latest updates as they become available.
Pre-recorded video presentations from local speakers and government officials is also being considered. We are open to new ideas, so if you have a suggestion please feel free to make contact and share your ideas.
Sponsorship & Exhibition Opportunities
Sponsorship of the ALLG’s Scientific Meetings provides broad company profiling, networking with lead clinicians, and opportunities for future research collaborations.
ALLG not only represents the premier cooperative blood cancer group in Australia, but is also a gathering of our top thought and opinion leaders. Therefore, sponsorship of the ALLG Scientific Meetings offers unrivalled exposure and recognition for your organisation.
ALLG meetings bring together Haematologists, Medical Oncologists, Radiation Oncologists, Scientists, Nurses, Pharmacists and Academic Researchers from across Australia and New Zealand, giving you an opportunity to interact with experts in the field of blood cancer research and management.